Sarepta Therapeutics, Inc. SEC filings SRPT
Sarepta Therapeutics, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to Mar 31, 2011. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Jul 28, 2026 | — |
| S-8 | Employee stock plan registration | Jun 4, 2026 | — |
| S-8 | Employee stock plan registration | Aug 6, 2025 | — |
| S-3ASR | Automatic shelf registration | Mar 3, 2025 | — |
| S-8 | Employee stock plan registration | Aug 7, 2024 | — |
| S-8 POS | Filing | Mar 28, 2024 | — |
| S-8 POS | Filing | Mar 28, 2024 | — |
| S-8 POS | Filing | Mar 28, 2024 | — |
| S-8 POS | Filing | Mar 28, 2024 | — |
| S-8 | Employee stock plan registration | Aug 2, 2023 | — |
| S-8 | Employee stock plan registration | Aug 2, 2022 | — |
| S-3ASR | Automatic shelf registration | Mar 2, 2022 | — |
| 424B5 | Prospectus supplement | Oct 15, 2021 | — |
| 424B5 | Prospectus supplement | Oct 12, 2021 | — |
| S-8 | Employee stock plan registration | Aug 5, 2020 | — |
| S-3ASR | Automatic shelf registration | Nov 14, 2019 | — |
| S-8 | Employee stock plan registration | Sep 11, 2019 | — |
| 424B5 | Prospectus supplement | Mar 7, 2019 | — |
| 424B5 | Prospectus supplement | Mar 5, 2019 | — |
| S-3ASR | Automatic shelf registration | Feb 28, 2019 | — |
| S-8 | Employee stock plan registration | Dec 7, 2018 | — |
| 424B5 | Prospectus supplement | Nov 9, 2018 | — |
| 424B5 | Prospectus supplement | Nov 8, 2018 | — |
| S-8 | Employee stock plan registration | Nov 1, 2017 | — |
| 424B5 | Prospectus supplement | Jul 25, 2017 | — |
| 424B5 | Prospectus supplement | Jul 24, 2017 | — |
| 424B5 | Prospectus supplement | Sep 23, 2016 | — |
| 424B5 | Prospectus supplement | Sep 21, 2016 | — |
| S-8 | Employee stock plan registration | Aug 9, 2016 | — |
| 424B5 | Prospectus supplement | Jun 10, 2016 | — |
| FWP | Free writing prospectus | Jun 8, 2016 | — |
| S-8 | Employee stock plan registration | Feb 25, 2016 | — |
| S-3ASR | Automatic shelf registration | Feb 25, 2016 | — |
| 424B5 | Prospectus supplement | Oct 6, 2015 | — |
| 424B5 | Prospectus supplement | Oct 5, 2015 | — |
| POS AM | Filing | Mar 2, 2015 | — |
| S-8 | Employee stock plan registration | Sep 30, 2014 | — |
| 424B5 | Prospectus supplement | Apr 24, 2014 | — |
| 424B5 | Prospectus supplement | Apr 23, 2014 | — |
| S-8 | Employee stock plan registration | Nov 12, 2013 | — |
| S-8 POS | Filing | Aug 20, 2013 | — |
| S-8 POS | Filing | Aug 20, 2013 | — |
| S-8 POS | Filing | Aug 20, 2013 | — |
| 424B5 | Prospectus supplement | Jul 3, 2013 | — |
| POS AM | Filing | Jun 7, 2013 | — |
| 424B5 | Prospectus supplement | Dec 14, 2012 | — |
| 424B5 | Prospectus supplement | Dec 12, 2012 | — |
| S-3ASR | Automatic shelf registration | Nov 7, 2012 | — |
| 424B5 | Prospectus supplement | Sep 19, 2012 | — |
| 424B5 | Prospectus supplement | Sep 4, 2012 | — |
| S-3 | Shelf registration | Mar 21, 2012 | — |
| S-8 | Employee stock plan registration | Jun 20, 2011 | — |
| 424B5 | Prospectus supplement | Apr 1, 2011 | — |
| 424B5 | Prospectus supplement | Mar 31, 2011 | — |
Showing 54 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SRPT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 873303
- Former names
- Sarepta Therapeutics, Inc. (until Nov 5, 2026); AVI BIOPHARMA INC (until Jul 12, 2012); ANTIVIRALS INC (until May 12, 1998)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.